← Eichor
Study identifier: NCT06172660 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Real-World Effectiveness of Perinatal RSV Immunoprophylaxis

Condition: RSV Infection  ·  Sponsor: Yale University

PhaseN/A
Planned participants3750
Who can joinAll sexes, N/A to 12 Months
Healthy volunteersNo

About this study

The purpose of this study is to continue evaluating how well the RSV vaccines work as they are currently being used in routine clinical practice. Some of the questions that the investigators hope to answer with this study are: 1) What is the overall effectiveness of these vaccines? 2) How long does immunity last? 3) How effective are the vaccines against new strains? 3) Does the vaccine's effectiveness vary by age?

This description comes directly from the study's public registry record.

Talk to the study team

Carlos R Oliveira, MD  ·  203-785-5474  ·  carlos.oliveira@yale.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Yale Child Health Research CenterNew Haven, Connecticut, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06172660